CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-23 | Coulie Bernard President and CEO | Sale | −4,850 | $34.93 | $169K | 93,812 |
| 2023-01-23 | Coulie Bernard President and CEO | Sale | −15,000 | $35.00 | $525K | 434,317 |
| 2023-01-23 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −15,000 | 232,380 | ||
| 2023-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Exercise or conversion | +10,000 | $11.86 | $119K | 15,947 |
| 2023-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Exercise or conversion | +10,000 | $24.32 | $243K | 25,947 |
| 2023-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Sale | −20,000 | $34.19 | $684K | 5,947 |
| 2023-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Exercise or conversion · Stock Option (right to buy) | −10,000 | 77,000 | ||
| 2023-01-23 | Ouimette Mike General Counsel & Corp. Sec'y | Exercise or conversion · Stock Option (right to buy) | −10,000 | 98,240 | ||
| 2023-01-23 | Lefebvre Eric Chief Medical Officer | Sale | −67,500 | $34.48 | $2.3M | 76,926 |
| 2023-01-23 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +12,500 | $2.08 | $26K | 96,924 |
| 2023-01-23 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +17,500 | $6.22 | $109K | 114,424 |
| 2023-01-23 | Cummings Keith Lamont Chief Financial Officer | Sale | −30,000 | $35.00 | $1.1M | 84,424 |
| 2023-01-23 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −12,500 | 133,597 | ||
| 2023-01-23 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −17,500 | 18,198 | ||
| 2023-01-19 | Cheung Lily Chief Human Resource Officer | Grant or award · Stock Option (Right to Buy) | +123,000 | 123,000 | ||
| 2023-01-09 | Coulie Bernard President and CEO | Exercise or conversion | +5,000 | $2.08 | $10K | 98,812 |
| 2023-01-09 | Coulie Bernard President and CEO | Sale | −5,000 | $19.17 | $96K | 93,812 |
| 2023-01-09 | Coulie Bernard President and CEO | Exercise or conversion · Stock Option (right to buy) | −5,000 | 247,380 | ||
| 2023-01-06 | Coulie Bernard President and CEO | Exercise or conversion | +15,000 | $2.08 | $31K | 108,812 |
| 2023-01-06 | Coulie Bernard President and CEO | Sale | −15,000 | $19.04 | $286K | 93,812 |
Page 12 of 19 · 379 trades